Category: Colon cancer

Home / Established Year

Colorectal cancer awareness month
,

March month is colorectal cancer awareness month

March 2023: In 2020, nearly 2 million cases of colorectal cancer will be diagnosed globally, making it the third most prevalent cancer type. It is the second leading cause of cancer-related deaths, accounting for nearly 1 million..

OG-Tukysa-logo
, , , , ,

Accelerated approval is granted by FDA to tucatinib with trastuzumab for colorectal cancer

In February 2023, the Food and Drug Administration (FDA) sped up the approval of tucatinib (Tukysa, Seagen Inc.) and trastuzumab for the treatment of RAS wild-type HER2-positive colorectal cancer that has spread or can not be rem..

, , , ,

All participants in a small cancer trial achieved complete remission

June 2022: A small study of rectal cancer patients yielded extraordinary results: 100 percent of the individuals were in remission. The results were published in The New England Journal of Medicine this week.The trial was funded ..

, ,

Weight loss is linked to decreased risk of colon and rectal polyps

May 2022: According to study findings published February 1 in the Journal of the National Cancer Institute, overweight or obese adults who lose more than 5 pounds over five years have a 46 percent lower risk of developing precanc..

Colorectal cancer latest screening guidelines

July 6th 2021 : Colorectal cancer is the among most prevalent cause of cancer death in the the world. Regular screening, on the other hand, can detect colorectal cancer while it is tiny, hasn't spread, and may be easier to treat...

Gastrointestinal stromal tumor targeting drug Avapritinib

Gastrointestinal stromal tumor targeting drug Avapritinib (Avapriny, Ayvakit, BLU-285) is approved by USFDA on 9th January, 2020. The drug covers two indications: for the treatment of adult patients with inoperable resection or m..

Colorectal cancer PD-1 / PD-L1 treatment

Colon cancer immunotherapy, rectal cancer immunotherapy, colorectal cancer immunotherapy, and colorectal cancer PD-1 / PD-L1 treatment. Seventeen years ago, the number of drugs available for advanced colorectal cancer was very li..

Braftovi with Erbitux finally achieved positive results for colorectal cancer

Targeted treatment of colorectal  cancer, BRAF V600E gene mutation targeted therapy of colorectal cancer Braftovi + Erbitux finally achieved positive resultsColorectal cancer treatment statusColorectal cancer is one of the most c..

How to prevent and treat relapsed colorectal cancer?

How to prevent relapse of colorectal cancer, how to treat relapse of  colorectal cancer after surgery?Colorectal cancer is a common malignant tumor, including colon cancer and rectal cancer. The incidence of colorectal cancer fro..

Intestinal cancer self-test, how to check for intestinal cancer?

Intestinal cancer self-test, how to check intestinal cancer, colorectal cancer screening, rectal cancer check, what check for rectal cancer, what check for suspected bowel cancer.Bowel cancer (usually referred to as colorectal can..

Newer
Start chat
Need help with cancer treatment?
Scan the code
Hello,
Welcome to CancerFax !

CancerFax is the most trusted international patient facilitator working with top cancer hospital's in the world like MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Beijing Cancer Institute and Apollo to bring you best of therapies and drugs.

Let us know what services would you like to avail?

1) Cancer treatment in the USA, Japan, Israel, India, Korea or Singapore?
2) CAR T-Cell therapy treatment
3) Cancer vaccine
4) Online video consultation
5) Proton therapy